Journal of Virology · 2002 · 66 citations · 24 references
Life SciencesBiochemistryMolecular BiologyMolecular VirologyStructural BiologyVirologyAntiretroviral TherapyAntiviral Drug ResistanceAntiviral ResistanceEnzyme InhibitionMolecular DockingPolymerase Chain ReactionAntiviral Resistance MutationsDrug Resistance MutationsHiv Antiretroviral TherapyNon-nucleoside InhibitorsNon-nucleoside Reverse Transcriptase InhibitorsNonnucleoside InhibitorsNucleoside Reverse Transcriptase InhibitorsReverse Transcriptase Inhibitor Resistance
Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70R, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.
24
T. Alwyn Jones, Jin-yu Zou, Sandra W. Cowan et al. · Acta Crystallographica Section A Foundations of Crystallography · 1991 · 12.7K citations